|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-5-14
|
|
pubmed:abstractText |
Angiotensin II receptor antagonists have been shown to moderately lower portal pressure in some patients with cirrhosis but may have adverse effects on kidney function. This study aimed at comparing the effects of a combined treatment using irbesartan plus propranolol with propranolol monotherapy on portal pressure and kidney function in patients with cirrhosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1572-0241
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1152-8
|
|
pubmed:meshHeading |
pubmed-meshheading:18422814-Adrenergic beta-Antagonists,
pubmed-meshheading:18422814-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:18422814-Antihypertensive Agents,
pubmed-meshheading:18422814-Biphenyl Compounds,
pubmed-meshheading:18422814-Dose-Response Relationship, Drug,
pubmed-meshheading:18422814-Double-Blind Method,
pubmed-meshheading:18422814-Female,
pubmed-meshheading:18422814-Humans,
pubmed-meshheading:18422814-Hypertension, Portal,
pubmed-meshheading:18422814-Liver Cirrhosis,
pubmed-meshheading:18422814-Liver Cirrhosis, Alcoholic,
pubmed-meshheading:18422814-Liver Function Tests,
pubmed-meshheading:18422814-Male,
pubmed-meshheading:18422814-Middle Aged,
pubmed-meshheading:18422814-Natriuresis,
pubmed-meshheading:18422814-Portal Pressure,
pubmed-meshheading:18422814-Propranolol,
pubmed-meshheading:18422814-Renin,
pubmed-meshheading:18422814-Tetrazoles
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Irbesartan plus low-dose propranolol versus low-dose propranolol alone in cirrhosis: a placebo-controlled, double-blind study.
|
|
pubmed:affiliation |
Department of Internal Medicine I, University of Bonn, Bonn, Germany.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
